Overview
Cellulitis is a common bacterial infection of the skin’s deeper layers (dermis and subcutaneous tissue). It typically appears as a painful, red, and swollen area that can spread quickly.
- Who it affects: Anyone can develop cellulitis, but it is most frequent in adults ≥ 50 years, people with chronic skin conditions, diabetes, or compromised immune systems.
- Prevalence: In the United States, cellulitis accounts for approximately 700,000 emergency‑department visits each year, making it one of the most common skin‑and‑soft‑tissue infections (CDC, 2023). Worldwide, incidence estimates range from 1.0 to 1.5 cases per 1,000 persons annually.
Early recognition and treatment are essential because the infection can progress to life‑threatening complications such as sepsis or necrotizing fasciitis.
Symptoms
The clinical picture can vary, but the following signs are most typical:
- Redness (erythema): A well‑defined, expanding area of red skin, often warm to the touch.
- Swelling (edema): The affected region feels puffy and may feel firm.
- Pain or tenderness: Discomfort can range from mild aching to severe throbbing.
- Heat: The skin feels hotter than surrounding tissue.
- Fever & chills: Systemic signs occur in about 30–50 % of cases.
- Skin changes: The area may become shiny, stretched, or develop small blisters (bullae).
- Red streaks (lymphangitis): Linear, reddish lines extending toward regional lymph nodes indicate spread through lymphatic vessels.
- Regional lymphadenopathy: Swollen, tender lymph nodes near the infection.
- General feeling of illness: Fatigue, malaise, or loss of appetite.
In infants and older adults, symptoms may be subtler, and fever may be the first clue.
Causes and Risk Factors
What causes cellulitis?
Cellulitis is usually caused by bacteria entering a break in the skin. The most frequent pathogens are:
- Streptococcus pyogenes (Group A Strep) – responsible for up to 70 % of cases.
- Staphylococcus aureus – including methicillin‑resistant strains (MRSA).
Less commonly, Gram‑negative rods (e.g., Pseudomonas) or anaerobes may be involved, especially in foot infections of diabetic patients.
Risk factors that increase susceptibility
- Skin breaks: cuts, abrasions, tattoos, insect bites, surgical wounds, or chronic ulcers.
- Underlying skin disease: eczema, psoriasis, chronic dermatitis.
- Peripheral vascular disease or lymphatic obstruction (lymphedema).
- Diabetes mellitus – high glucose impairs immune response and wound healing.
- Immunosuppression: HIV/AIDS, chemotherapy, long‑term corticosteroids.
- Obesity – larger skin surface area and poorer circulation.
- Recent trauma or surgery, especially in the lower extremities.
- Previous episodes of cellulitis – recurrence risk 30 % within 5 years.
Diagnosis
Clinical assessment
Diagnosis is primarily clinical. A healthcare provider will:
- Take a thorough history (onset, prior skin lesions, comorbidities).
- Inspect the skin for characteristic redness, swelling, and warmth.
- Palpate for tenderness, fluctuance (suggesting an abscess), and lymphadenopathy.
Laboratory & imaging studies
- Complete blood count (CBC): Often shows leukocytosis with left shift.
- Blood cultures: Recommended for patients with fever, systemic signs, or suspected bacteremia (≈10 % yield).
- Wound swab or aspirate: If an abscess or ulcer is present, culture guides antibiotic choice.
- Imaging:
- Ultrasound – Detects underlying abscesses that may need drainage.
- CT or MRI – Reserved for atypical presentations or when necrotizing fasciitis is suspected.
In most uncomplicated cases, no lab tests are required beyond CBC; treatment can begin based on clinical suspicion.
Treatment Options
Antibiotic therapy
First‑line oral antibiotics target Streptococcus and MSSA (methicillin‑susceptible S. aureus):
- Penicillin V or amoxicillin‑clavulanate
- Cephalexin 500 mg q6h (or 1 g q12h) for 5‑10 days
- Doxycycline or clindamycin for suspected MRSA or penicillin allergy
For severe infection, hospitalization and intravenous (IV) therapy are indicated:
- IV cefazolin, ceftriaxone, or nafcillin for MSSA
- IV vancomycin or linezolid for MRSA
Duration: 5–7 days for uncomplicated cellulitis; up to 14 days for deeper or slower‑responding infections.
Adjunctive measures
- Elevation: Keep the affected limb above heart level to reduce edema.
- Analgesia: Acetaminophen or ibuprofen for pain and fever.
- Warm compresses: May improve comfort but should not replace antibiotics.
Surgical intervention
If an abscess or necrotic tissue is present, incision and drainage (I&D) are required. Prompt I&D combined with antibiotics reduces treatment failure rates.
Lifestyle & supportive care
- Maintain good hydration and nutrition to support immune function.
- Control blood glucose aggressively in diabetics (target <130 mg/dL fasting).
- Stop smoking – it impairs circulation and wound healing.
Living with Skin Cellulitis
Daily management tips
- Complete the antibiotic course: Even if symptoms improve after 2–3 days, finish the full regimen to prevent relapse or resistance.
- Skin care: Keep the area clean, gently wash with mild soap, and pat dry.
- Moisturize: Use fragrance‑free emollients to prevent fissures.
- Monitor: Check the infection daily for spreading redness, new pain, or fever.
- Compression garments: For patients with chronic edema or lymphedema, properly fitted compression socks can reduce recurrence.
- Foot care for diabetics: Inspect feet at least once daily; treat minor cuts promptly.
When to follow up
Schedule a follow‑up visit within 48‑72 hours of starting antibiotics (or sooner if symptoms worsen). Patients with chronic illness may need more frequent monitoring.
Prevention
- Maintain skin integrity: Trim nails, treat fungal infections, and avoid harsh chemicals.
- Prompt wound care: Clean minor cuts with soap and water, apply an antibiotic ointment, and cover with a sterile bandage.
- Manage chronic conditions: Keep diabetes, peripheral vascular disease, and lymphedema under control.
- Weight management: Achieve a healthy BMI to lessen pressure on lower‑extremity skin.
- Vaccination: While no vaccine prevents cellulitis, staying up‑to‑date on influenza and pneumococcal vaccines reduces overall infection risk in vulnerable populations.
- Hand hygiene: Wash hands before touching wounds.
Complications
If left untreated or inadequately treated, cellulitis can progress to serious conditions:
- Abscess formation: Localized pocket of pus requiring drainage.
- Lymphangitis: Inflammation of lymphatic channels, evident as red streaks.
- Septicemia (blood infection): Can lead to organ failure; mortality up to 15 % in severe cases.
- Necrotizing fasciitis: Rapidly spreading “flesh‑eating” infection—requires emergency surgery.
- Chronic lymphedema or venous insufficiency: Recurring cellulitis may permanently damage lymphatic drainage.
- Scarring or pigmentation changes: Cosmetic concerns after healing.
When to Seek Emergency Care
- Rapid spreading of redness (more than 2 cm per hour) or sudden increase in swelling.
- Severe pain disproportionate to the visible skin changes.
- Fever ≥ 101.5 °F (38.6 °C) with chills, especially with confusion or shortness of breath.
- Red streaks (lymphangitis) moving toward the groin, armpit, or neck.
- Signs of sepsis: rapid heartbeat, low blood pressure, mental status changes, or decreased urine output.
- Swelling or pain in the face, neck, or genital area.
- Recent trauma with an open wound that is rapidly worsening.
Early emergency treatment can prevent life‑threatening complications.
References
- Centers for Disease Control and Prevention. “Cellulitis.” 2023. https://www.cdc.gov/skin-and-wound-infections/cellulitis.html
- Mayo Clinic. “Cellulitis.” Updated 2022. https://www.mayoclinic.org
- National Institute of Allergy and Infectious Diseases. “Skin and Soft Tissue Infections.” 2021. https://www.niaid.nih.gov
- Cleveland Clinic. “Cellulitis – Symptoms, Causes, Treatment.” 2022. https://my.clevelandclinic.org
- World Health Organization. “Antibiotic Resistance.” 2023. https://www.who.int